Previous Article | Next Article ![]()
Journal of Virology, October 2000, p. 9002-9009, Vol. 74, No. 19
Department of Medical Biochemistry and
Microbiology, BMC, Uppsala University, SE-751 23 Uppsala, Sweden
Received 30 March 2000/Accepted 14 July 2000
Expression of cytoplasmic mRNA from most adenovirus
transcription units is subjected to a temporal regulation at the level of alternative pre-mRNA splicing. The general tendency is that splice site selection changes from proximal to distal late after infection. Interestingly, ASF/SF2, which is a prototypical member of
the SR family of splicing factors, has the opposite effect on splice
site selection, inducing an increase in proximal splice site usage. We
have previously shown that SR proteins late during an adenovirus
infection become partially inactivated as splicing regulatory proteins.
A prediction from these results is that overexpression of an SR
protein, such as ASF/SF2, during virus growth will interfere with virus
replication by disturbing the balance of functional and nonfunctional
ASF/SF2 in the infected cell. To test this hypothesis, we reconstructed
a recombinant adenovirus expressing ASF/SF2 under the transcriptional
control of a regulated promoter. The results show that, as predicted,
induction of ASF/SF2 during lytic virus growth prevents the early to
late shift in mRNA expression from both early (E1A and E1B) and
late (L1) transcription units. Furthermore, ASF/SF2 overexpression
blocks viral DNA replication and reduces selectively cytoplasmic
accumulation of major late mRNA, resulting in a lower virus yield.
Collectively, our results provide additional support for the hypothesis
that viral control of SR protein function is important for the proper
expression of viral proteins during lytic virus growth.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Overexpression of Essential Splicing Factor ASF/SF2 Blocks the
Temporal Shift in Adenovirus Pre-mRNA Splicing and Reduces
Virus Progeny Formation
*
Corresponding author. Mailing address: Department of
Medical Biochemistry and Microbiology, BMC, Box 582, Uppsala
University, SE-751 23 Uppsala, Sweden. Phone: 46-18-471 41 64. Fax:
46-18-50 98 76. E-mail: goran.akusjarvi{at}imim.uu.se.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|